The Increased Product Launch is Propelling the Growth of the PCR Test Market in the APAC Region!
- Vikas Kumar
- July 28, 2023
- HEALTHCARE, NEWS
- PCR Test Market
- 0 Comments
The Asia-Pacific (APAC) region is an important and growing market for PCR tests. The region includes countries such as China, India, Japan, and Australia, which have large and rapidly aging populations, and increasing incidences of various genetic and infectious disorders. The growing incidence of infectious diseases, increasing awareness about the benefits of early disease detection, rising investments in healthcare infrastructure, and technological advancements in PCR equipment and reagents. For instance, as per the studies published in NCBI, the prevalence of genetic disorders is high in Japan out of 100 children born in Japan 1 child suffers from a genetic disorder.
Access sample report (including graphs, charts, and figures): https://univdatos.com/report/pcr-test-market/get-a-free-sample-form.php?product_id=42662
Further, the Asia-Pacific PCR test Market is expected to grow at a strong CAGR of 8% during the forecast period (2022-2030) owing to frequent product launches. For instance, in April 2023, Vanguard Diagnostics launched India’s first typhoid RT-PCR test. The VANSCAN Typhoid RT PCR test is the new gold standard, reliable, fast, and compatible with all open RT PCR systems.
APAC PCR test Market Revenue (2020-2030)- USD Mn
For a detailed analysis of the Global PCR test Market browse through https://univdatos.com/report/pcr-test-market/
Based on type, the market is segmented into standard PCR, real-time PCR, digital PCR, and others. The real-time PCR segment acquired a major share in 2021. RT-PCR is one of the most widely used and preferred methods for COVID-19 testing. The PCR test market has experienced significant growth since the start of the COVID-19 pandemic, with demand for testing kits and related products increasing rapidly. Further, the RT PCR gives accurate results and provides real-time results which is also an important factor for the high share of segment in the PCR test market.
Based on the product, the market is segmented into instruments, reagents & consumables, and software & services. The reagents & consumables segment held a prominent share in 2021. Reagents and consumables are essential components of the PCR test market, as they are necessary for conducting PCR tests and producing reliable results. PCR reagents include various enzymes, such as Taq polymerase and reverse transcriptase, as well as buffers, nucleotides, and other chemicals required for amplifying and detecting the genetic material of interest. These are the several reasons for the dominating share of reagents & consumables in the PCR test market.
Based on the end-user, the market is segmented into hospitals & clinics, pharmaceuticals & biotechnology industries, and diagnostics centers. The diagnostics centers segment is expected to grow with the highest CAGR during the forecast period. The fast and accurate results offered by the diagnostic centers and the availability of at-home sample collection are the important factors responsible for the fast growth of diagnostics centers in the PCR test market.
Global PCR Test Market Segmentation
Market Insight, by Type
· Standard PCR
· Real-time PCR
· Digital PCR
· Others
Market Insight, by Product
· Instruments
· Reagents & Consumables
· Software & Services
Market Insight, by Indication
· Infectious Diseases
· Oncology
· Genetic Disorders
· Others
Market Insight, by End-User
· Hospitals & Clinics
· Pharmaceuticals & Biotechnology Industries
· Diagnostics Centers
· Others
Market Insight, by Region
· North America
o U.S.
o Canada
o Rest of North America
· Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe
· APAC
o China
o Japan
o India
o Rest of APAC
· Rest of the World
Top Company Profiles
· Abbott
· Agilent Technologies, Inc.
· BIOMÉRIEUX
· Bio-Rad Laboratories, Inc.
· F. Hoffmann-La Roche Ltd.
· QIAGEN
· GenMark Diagnostics, Inc.
· Thermo Fisher Scientific Inc.
· General Electric
· Danaher
